Rpl24(Bst) mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K

Files

hdl_134248.pdf (1.81 MB)
  (Published version)

Date

2021

Authors

Knight, J.R.P.
Vlahov, N.
Gay, D.M.
Ridgway, R.A.
Faller, W.J.
Proud, C.
Mallucci, G.R.
von der Haar, T.
Smales, C.M.
Willis, A.E.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

eLife, 2021; 10:e69729-1-e69729-25

Statement of Responsibility

John RP Knight, Nikola Vlahov, David M Gay, Rachel A Ridgway, William James Faller, Christopher Proud, Giovanna R Mallucci, Tobias von der Haar, Christopher Mark Smales, Anne E Willis, Owen J Sansom

Conference Name

Abstract

Increased protein synthesis supports the rapid cell proliferation associated with cancer. The Rpl24(Bst) mutant mouse reduces the expression of the ribosomal protein RPL24 and has been used to suppress translation and limit tumorigenesis in multiple mouse models of cancer. Here, we show that Rpl24(Bst) also suppresses tumorigenesis and proliferation in a model of colorectal cancer (CRC) with two common patient mutations, Apc and Kras. In contrast to previous reports, Rpl24(Bst) mutation has no effect on ribosomal subunit abundance but suppresses translation elongation through phosphorylation of eEF2, reducing protein synthesis by 40% in tumour cells. Ablating eEF2 phosphorylation in Rpl24Bst mutant mice by inactivating its kinase, eEF2K, completely restores the rates of elongation and protein synthesis. Furthermore, eEF2K activity is required for the Rpl24(Bst) mutant to suppress tumorigenesis. This work demonstrates that elevation of eEF2 phosphorylation is an effective means to suppress colorectal tumorigenesis with two driver mutations. This positions translation elongation as a therapeutic target in CRC, as well as in other cancers where the Rpl24Bst mutation has a tumour suppressive effect in mouse models.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2021, Knight et al. This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

License

Grant ID

Call number

Persistent link to this record